These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Author: Traub WH.
    Journal: Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026.
    Abstract:
    Spontaneous and selected variants of Serratia marcescens with resistance against chloramphenicol, cotrimoxazole, nalidixic acid, and pipemidic acid, revealed moderately reduced susceptibility for enoxacin and norfloxacin, and slightly diminished susceptibility for ciprofloxacin. Therefore, urinary tract infections due to S. marcescens strains showing this nonspecific resistance mechanism still might be amenable to judicious chemotherapy with these three novel bacterial DNA gyrase inhibitors, particularly ciprofloxacin.
    [Abstract] [Full Text] [Related] [New Search]